Sinopharm (01099.HK) announced that Zhao Bingxiang has been appointed as a non-executive director of the company, and Lian Wanyong has been appointed as an executive director.
The board of directors of the company announced that non-executive director Zhao Bingxiang has been appointed as the chairman of the board nomination committee, the chairman of the board strategy and investment committee, and a member of the board legal compliance and environmental, social and governance committee, and that executive director Lian Wanyong has been appointed as a member of the board strategy and investment committee and the board legal compliance and environmental, social and governance committee. These appointments will take effect on September 14, 2024.
